Dr. Nimrta Ghuman, MD

Dr. Ghuman practices at U.S. Renal Care South York Dialysis in York, Pennsylvania.

Dr. Ghuman's NPI, 1871792960, was assigned on July 17, 2007. Dr. Ghuman holds Pennsylvania license MD446506.

Dr. Ghuman's primary practice is U.S. Renal Care South York Dialysis, at 1920 Queenswood Dr, York, PA 17403 in York County. The practice phone is (717) 430-5232.

Dr. Ghuman's primary practice is U.S. Renal Care South York Dialysis in York, Pennsylvania. Dr. Ghuman is also affiliated with WellSpan York Hospital. The medical group on file is Nephrology Associates of York, P.C. Dmand AI also links Dr. Ghuman to 4 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghuman practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ghuman's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ghuman is licensed in Pennsylvania.

CMS data shows 1,187 Medicare services from Dr. Ghuman across 10 procedure codes in 2024, for 300 Medicare patients. Medicare paid $120,947 for them.

CMS counts 300 Medicare patients who saw Dr. Ghuman in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 4.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghuman's median patient age at 73, with 41% women.

In 2024, Dr. Ghuman wrote 997 Medicare Part D claims for 158 patients. 86% of them were for generic drugs. CMS names the drug for 788 of them, across 20 drugs with 11 or more claims each, at $100,169 in total drug cost. In 2023, CMS named 640 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ghuman for performance year 2024, reported as part of a group. Dr. Ghuman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghuman as offering telehealth.

Dmand AI links 3 papers to Dr. Ghuman in 2012. 2012 was the busiest year, with 2. The most frequent topics are Brachial Artery, Coronary Disease and Diabetes Mellitus, Type 2. Dr. Ghuman's most frequent co-author is Joanne M. Murabito, MD.

CMS Open Payments shows 150 general payments to Dr. Ghuman from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $324.